Dongwha Pharmaceutical Plans Tougher Penalties for Compliance Violations
Dongwha Pharmaceutical plans to strengthen penalties for violations of its fair-trade compliance program in Q4 2026, with corporate-card checks and on-site inspections.
Dongwha Pharmaceutical plans to strengthen penalties for violations of its fair-trade compliance program in Q4 2026, with corporate-card checks and on-site inspections.